News

ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC

FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical…

2 years ago

WIMI Hologram Academy: The Application of Virtual reality online games in Information Communication in the 5G era

HONG KONG, June 16, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

2 years ago

22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid…

2 years ago

PepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments

BOSTON, June 16, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide…

2 years ago

Broken Coast Cannabis Launches Full Spectrum ‘woah’

A New Summer Lineup of Premium Craft-Cannabis Products Including, Liquid Wax, BHO Vapes, and Premium Small-Batch Flower Now Available Across…

2 years ago

Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer…

2 years ago

INmune Bio, Inc. Presents Data on Combination Therapy with INB03™ on Overcoming Resistance to HER2 Targeted Therapies in Breast Cancer

In pre-clinical models of trastuzumab resistant MUC4 HER2+ breast cancer, treatment with INB03™ decreases MUC4 expression, reverses resistance to trastuzumab…

2 years ago

Nova Mentis Files Patent on Diagnosing, Monitoring and Treating Neurological Diseases with Psychoactive Tryptamine Derivatives

mRNA Diagnostic Index to Measure Drug Treatment ResponseVancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Nova Mentis Life Science…

2 years ago

CBD of Denver Accelerates Expansion Plans with Strategic Priorities Set for Second Half of 2022

Denver, Colorado--(Newsfile Corp. - June 16, 2022) -  CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and…

2 years ago

Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the…

2 years ago